Answers are grounded in this paper and cite their sources.
Age-associated changes in circulating factors contribute to blood-brain barrier (BBB) dysfunction, yet the relative effects of serum and serum-derived extracellular vesicles (EVs) remain unclear. Here, we used a human multicellular transwell BBB model, composed of primary brain microvascular endothelial cells (BMECs), astrocytes, pericytes, and neural progenitor cells (hNPCs) derived from human induced pluripotent stem cells (iPSCs), to compare the effects of serum and serum-derived EVs from young-adult and aged mice on BBB integrity. Barrier function was assessed by transendothelial electrical resistance (TEER) and permeability to 3-5 and 40 kDa FITC-dextran, and cellular organization and junctional integrity were evaluated by immunofluorescence. Although TEER exhibited treatment-dependent differences, permeability assays revealed distinct age- and treatment-associated changes in macromolecular transport. Aged EVs increased permeability to both dextran tracers relative to young EVs and markedly reduced ZO-1 coverage, whereas aged serum produced the greatest permeability to the 40 kDa tracer and the most pronounced loss of BMEC alignment. These changes occurred without a significant reduction in overall vWF-positive endothelial area, indicating structural and functional remodeling rather than overt endothelial loss. Additionally, young serum increased TUJ1-positive area and claudin-5 coverage, pointing to broader cell-type-specific effects. Together, these findings show that aging shifted the BBB toward greater macromolecular permeability and poorer endothelial organization, with aged EVs acting primarily on junctional integrity and aged serum driving the larger increase in permeability and loss of endothelial alignment.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: